Medivolve Inc
OTC:MEDVF
Medivolve Inc
OTC:MEDVF
Price:
0.0001
USD
Market Closed
Market Cap:
$30k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medivolve Inc
OTC:MEDVF
|
CA |
|
Tasty PLC
LSE:TAST
|
UK |
|
A
|
Asdion Bhd
KLSE:ASDION
|
MY |
|
Kirby Corp
NYSE:KEX
|
US |
|
Guardforce AI Co Ltd
NASDAQ:GFAI
|
TH |
|
Towa Corp
TSE:6315
|
JP |
|
N
|
Nexgen Energy Ltd
NYSE:NXE
|
CA |
|
C
|
Champ Resto Indonesia Tbk PT
IDX:ENAK
|
ID |
Balance Sheet
Balance Sheet Decomposition
Medivolve Inc
Medivolve Inc
Balance Sheet Decomposition is not available for
Medivolve Inc
Medivolve Inc
Balance Sheet
Medivolve Inc
Medivolve Inc
Currency: CAD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
1
|
5
|
4
|
0
|
1
|
0
|
4
|
1
|
|
| Cash Equivalents |
0
|
1
|
5
|
4
|
0
|
1
|
0
|
4
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
3
|
55
|
12
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
0
|
1
|
5
|
4
|
2
|
5
|
56
|
17
|
1
|
|
| PP&E Net |
1
|
1
|
0
|
0
|
0
|
9
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
2
+133%
|
5
+139%
|
5
-14%
|
2
-50%
|
19
+732%
|
59
+210%
|
19
-68%
|
2
-87%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
0
|
0
|
0
|
0
|
7
|
27
|
8
|
9
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
5
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
13
|
1
|
1
|
2
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
6
|
4
|
4
|
|
| Total Current Liabilities |
1
|
0
|
0
|
0
|
0
|
29
|
41
|
18
|
18
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Liabilities |
1
N/A
|
0
-91%
|
0
-69%
|
0
-13%
|
0
+798%
|
29
+9 123%
|
41
+42%
|
18
-55%
|
18
-2%
|
|
| Equity | ||||||||||
| Common Stock |
17
|
19
|
19
|
19
|
19
|
41
|
67
|
67
|
67
|
|
| Retained Earnings |
18
|
17
|
14
|
14
|
17
|
51
|
50
|
68
|
85
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
|
| Total Equity |
1
N/A
|
2
N/A
|
5
+152%
|
5
-14%
|
2
-56%
|
10
N/A
|
18
N/A
|
0
-98%
|
16
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+133%
|
5
+139%
|
5
-14%
|
2
-50%
|
19
+732%
|
59
+210%
|
19
-68%
|
2
-87%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
7
|
34
|
34
|
34
|
34
|
150
|
27
|
27
|
27
|
|
Switch to:
Switch to:
See Also
Discover More
